These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15264431)

  • 1. Gene expression profiling of anticancer immune responses.
    Wang E; Panelli MC; Monsurró V; Marincola FM
    Curr Opin Mol Ther; 2004 Jun; 6(3):288-95. PubMed ID: 15264431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene profiling of immune responses against tumors.
    Wang E; Panelli MC; Marincola FM
    Curr Opin Immunol; 2005 Aug; 17(4):423-7. PubMed ID: 15950448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cDNA arrays and the enigma of melanoma immune responsiveness.
    Wang E; Marincola FM
    Cancer J; 2001; 7(1):16-24. PubMed ID: 11269643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving strategies for global gene expression analysis of cancer.
    Coe BP; Chari R; Lockwood WW; Lam WL
    J Cell Physiol; 2008 Dec; 217(3):590-7. PubMed ID: 18680120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic strategies employing RNA interference technology for the control of cancers.
    Mao CP; Hung CF; Wu TC
    J Biomed Sci; 2007 Jan; 14(1):15-29. PubMed ID: 17103251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural immunity has significant impact on immune responses against cancer.
    Rubin B
    Scand J Immunol; 2009 Mar; 69(3):275-90. PubMed ID: 19281540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression.
    Liu K; Caldwell SA; Abrams SI
    Cancer Res; 2005 May; 65(10):4376-88. PubMed ID: 15899830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling as a tool for basic analysis and clinical application of human cancer.
    García-Escudero R; Paramio JM
    Mol Carcinog; 2008 Aug; 47(8):573-9. PubMed ID: 18324660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells.
    Spaner DE
    J Leukoc Biol; 2004 Aug; 76(2):338-51. PubMed ID: 15277580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene modification strategies to induce tumor immunity.
    Murphy A; Westwood JA; Teng MW; Moeller M; Darcy PK; Kershaw MH
    Immunity; 2005 Apr; 22(4):403-14. PubMed ID: 15845446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases.
    Covell DG; Wallqvist A; Huang R; Thanki N; Rabow AA; Lu XJ
    Proteins; 2005 May; 59(3):403-33. PubMed ID: 15778971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer approaches in cancer immunotherapy.
    Larin SS; Georgiev GP; Kiselev SL
    Gene Ther; 2004 Oct; 11 Suppl 1():S18-25. PubMed ID: 15454953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory B7-family molecules in the tumour microenvironment.
    Zou W; Chen L
    Nat Rev Immunol; 2008 Jun; 8(6):467-77. PubMed ID: 18500231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines.
    Thomas CW; Myhre GM; Tschumper R; Sreekumar R; Jelinek D; McKean DJ; Lipsky JJ; Sandborn WJ; Egan LJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):537-45. PubMed ID: 15388785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of non-small-cell lung cancer.
    Lacroix L; Commo F; Soria JC
    Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune suppression in the tumor microenvironment.
    Gajewski TF; Meng Y; Harlin H
    J Immunother; 2006; 29(3):233-40. PubMed ID: 16699366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of genes with increased expression in human glioblastomas.
    Kavsan V; Shostak K; Dmitrenko V; Zozulya Y; Rozumenko V; Demotes-Mainard J
    Tsitol Genet; 2005; 39(6):37-49. PubMed ID: 16396319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of cytokines for development of protective immunity and rational design of vaccines.
    Chabalgoity JA; Baz A; Rial A; Grille S
    Cytokine Growth Factor Rev; 2007; 18(1-2):195-207. PubMed ID: 17347024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.